AN2 Therapeutics, Inc.

Menlo Park, CA AN2 Therapeutics, Inc.

UEI
DD4FE2GE4L78
CAGE
822Z2
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1800 El Camino Real UNIT D, Menlo Park, CA 94025, USA
Website
an2therapeutics.com
Founded
2019
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

AN2 Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of epetraborole as a novel therapeutic for melioidosis and additional antimicrobial resistant (AMR)… Contract · 75N93022C00059 National Institute of Allergy and Infectious Diseases $9,235,577

Quick answers

What is AN2 Therapeutics, Inc.'s UEI?

AN2 Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is DD4FE2GE4L78.

What is AN2 Therapeutics, Inc.'s CAGE code?

AN2 Therapeutics, Inc.'s CAGE code is 822Z2.

What is AN2 Therapeutics, Inc.'s primary NAICS code?

AN2 Therapeutics, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is AN2 Therapeutics, Inc. located?

AN2 Therapeutics, Inc.'s physical address in SAM.gov is 1800 El Camino Real UNIT D, Menlo Park, CA 94025, USA.

Is AN2 Therapeutics, Inc. registered in SAM.gov?

AN2 Therapeutics, Inc.'s SAM.gov registration expired on June 24, 2026.

What is AN2 Therapeutics, Inc.'s most recent federal award?

AN2 Therapeutics, Inc.'s most recent federal contract award is Development of epetraborole as a novel therapeutic for melioidosis and additional antimicrobial resistant (AMR)… (75N93022C00059), from National Institute of Allergy and Infectious Diseases, on September 20, 2022.

On GovTribe

See AN2 Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors